Equine pegiviruses cause persistent infection of bone marrow and are not associated with hepatitis.
Journal
PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
10
04
2020
accepted:
02
06
2020
revised:
22
07
2020
pubmed:
11
7
2020
medline:
25
8
2020
entrez:
11
7
2020
Statut:
epublish
Résumé
Pegiviruses frequently cause persistent infection (as defined by >6 months), but unlike most other Flaviviridae members, no apparent clinical disease. Human pegivirus (HPgV, previously GBV-C) is detectable in 1-4% of healthy individuals and another 5-13% are seropositive. Some evidence for infection of bone marrow and spleen exists. Equine pegivirus 1 (EPgV-1) is not linked to disease, whereas another pegivirus, Theiler's disease-associated virus (TDAV), was identified in an outbreak of acute serum hepatitis (Theiler's disease) in horses. Although no subsequent reports link TDAV to disease, any association with hepatitis has not been formally examined. Here, we characterized EPgV-1 and TDAV tropism, sequence diversity, persistence and association with liver disease in horses. Among more than 20 tissue types, we consistently detected high viral loads only in serum, bone marrow and spleen, and viral RNA replication was consistently identified in bone marrow. PBMCs and lymph nodes, but not liver, were sporadically positive. To exclude potential effects of co-infecting agents in experimental infections, we constructed full-length consensus cDNA clones; this was enabled by determination of the complete viral genomes, including a novel TDAV 3' terminus. Clone derived RNA transcripts were used for direct intrasplenic inoculation of healthy horses. This led to productive infection detectable from week 2-3 and persisting beyond the 28 weeks of study. We did not observe any clinical signs of illness or elevation of circulating liver enzymes. The polyprotein consensus sequences did not change, suggesting that both clones were fully functional. To our knowledge, this is the first successful extrahepatic viral RNA launch and the first robust reverse genetics system for a pegivirus. In conclusion, equine pegiviruses are bone marrow tropic, cause persistent infection in horses, and are not associated with hepatitis. Based on these findings, it may be appropriate to rename the group of TDAV and related viruses as EPgV-2.
Identifiants
pubmed: 32649726
doi: 10.1371/journal.ppat.1008677
pii: PPATHOGENS-D-20-00732
pmc: PMC7375656
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1008677Subventions
Organisme : NIAID NIH HHS
ID : K08 AI141767
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
PLoS Pathog. 2010 Jul 01;6:e1000972
pubmed: 20617167
J Gen Virol. 2018 Jun;99(6):768-776
pubmed: 29658859
mBio. 2015 Sep 22;6(5):e01466-15
pubmed: 26396247
mBio. 2013 Apr 09;4(2):e00216-13
pubmed: 23572554
Infect Genet Evol. 2013 Oct;19:195-9
pubmed: 23871772
J Vet Intern Med. 2019 Jan;33(1):251-257
pubmed: 30520162
PLoS Pathog. 2015 Dec 11;11(12):e1005325
pubmed: 26658760
J Gen Virol. 2001 Apr;82(Pt 4):713-722
pubmed: 11257175
J Virol. 2006 Dec;80(24):12131-40
pubmed: 17035329
Hepatology. 2011 Dec;54(6):1901-12
pubmed: 22144107
Emerg Infect Dis. 2018 Feb;24(2):303-310
pubmed: 29350162
Vet Microbiol. 2020 Mar;242:108575
pubmed: 32122586
Annu Rev Virol. 2016 Sep 29;3(1):53-75
pubmed: 27741408
Hepatology. 2015 Feb;61(2):447-59
pubmed: 25212983
Acta Trop. 2015 Dec;152:56-59
pubmed: 26314230
J Gen Virol. 2018 Sep;99(9):1221-1226
pubmed: 30041711
Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8738-43
pubmed: 9238047
Sci Transl Med. 2015 Sep 16;7(305):305ra144
pubmed: 26378244
Trends Microbiol. 2012 Mar;20(3):124-30
pubmed: 22325031
J Med Virol. 2000 May;61(1):52-8
pubmed: 10745232
PLoS Pathog. 2013;9(6):e1003438
pubmed: 23818848
PLoS One. 2016 May 16;11(5):e0155662
pubmed: 27182887
J Virol. 1992 Nov;66(11):6649-54
pubmed: 1328684
Proc Natl Acad Sci U S A. 2013 May 14;110(20):8194-9
pubmed: 23610427
PLoS One. 2017 Dec 7;12(12):e0189208
pubmed: 29216266
Vet Microbiol. 2016;182:8-14
pubmed: 26711022
Equine Vet J. 2017 Mar;49(2):138-140
pubmed: 27995661
Emerg Infect Dis. 2016 Jul;22(7):1312-4
pubmed: 27314228
Science. 1996 Jan 26;271(5248):505-8
pubmed: 8560265
J Virol. 2013 Jun;87(12):7185-90
pubmed: 23596285
Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):2192-7
pubmed: 25646476
Hepatology. 1999 Jan;29(1):245-9
pubmed: 9862873
J Virol. 1998 Apr;72(4):3072-5
pubmed: 9525631
Virology. 1999 Sep 30;262(2):470-8
pubmed: 10502525
J Infect Dis. 2006 Feb 1;193(3):451-4
pubmed: 16388494
J Virol. 2000 Oct;74(19):9125-33
pubmed: 10982359
Science. 1997 Jul 25;277(5325):570-4
pubmed: 9228008
Equine Vet J. 2020 Mar 7;:
pubmed: 32145096
Arch Virol. 2018 Jan;163(1):249-252
pubmed: 29094242
Nucleic Acids Res. 2003 Jul 1;31(13):3406-15
pubmed: 12824337
Nat Biotechnol. 2019 Apr;37(4):420-423
pubmed: 30778233
J Gen Virol. 2014 Aug;95(Pt 8):1701-1711
pubmed: 24814924
J Vet Intern Med. 2019 Jan;33(1):258-265
pubmed: 30520132
Hepatology. 2018 Aug;68(2):435-448
pubmed: 28859226
J Virol. 2012 Jun;86(11):6171-8
pubmed: 22491452
J Gen Virol. 2014 Jun;95(Pt 6):1307-1319
pubmed: 24668525
mBio. 2014 Oct 14;5(5):e01933-14
pubmed: 25316698
Vet Med Sci. 2019 Aug;5(3):372-378
pubmed: 31267690
J Viral Hepat. 1998 May;5(3):153-9
pubmed: 9658367
Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):E1407-15
pubmed: 23509292
Virology. 1997 Mar 17;229(2):429-36
pubmed: 9126255
J Gen Virol. 2011 Feb;92(Pt 2):233-46
pubmed: 21084497
Antiviral Res. 2015 Mar;115:83-93
pubmed: 25545071
Emerg Microbes Infect. 2020 Dec;9(1):651-663
pubmed: 32192415
N Engl J Med. 2001 Sep 6;345(10):715-24
pubmed: 11547740
PLoS Pathog. 2017 Oct 26;13(10):e1006692
pubmed: 29073258
Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3401-5
pubmed: 7724574
Transbound Emerg Dis. 2019 Jul;66(4):1737-1751
pubmed: 31017727
Nat Med. 1995 Jun;1(6):564-9
pubmed: 7585124
J Gen Virol. 2016 Nov;97(11):2894-2907
pubmed: 27692039